LivaNova PLC

LIVN: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
kxLOCK|?dHnLOCK|h^

LivaNova Earnings: Steady Progress on Execution Is Paying Off

LivaNova's third quarter included top-line growth of 10% in constant currency and adjusted operating income up 15% year over year. Management raised the full-year outlook for both cardiopulmonary and neuromodulation growth by 100 basis points at the midpoint, for total sales growth of 9% to 10%.

Sponsor Center